Theranos’ health takes a turn for the worse

The health of ailing biotech start-up Theranos continues to decline, as the Centers for Medicare & Medicaid Services imposed numerous sanctions on the firm following a review last year of its laboratory operations that uncovered numerous compliance violations. Jaclyn Jaeger reports.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.